Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
May 21, 2026
Johnson & Johnson used an ellipsis to eliminate a professor's finding of asbestos in its talc in a report submitted to the U.S. Food and Drug Administration, according to a video deposition shown Thursday to a California jury considering bellwether claims over three women's deadly ovarian cancer.
-
May 21, 2026
A Ninth Circuit panel scrapped a ruling that directed the U.S. Environmental Protection Agency to take action to address potentially unsafe levels of drinking water fluoridation, concluding a California federal judge improperly commandeered the case.
-
May 21, 2026
Two reported NFL stake sales this past week highlight the continued surge in professional sports valuations, fueled in part by the entry of private equity investors.
-
May 21, 2026
A North Carolina federal judge found that a life sciences company's insurer can't avoid counterclaims brought by a former patent holder asserting that the carrier must cover a $1.77 million judgment entered against the company's executives after they were accused of making misrepresentations about taking the company public.
-
May 21, 2026
UCB Inc. has persuaded a Delaware federal judge to uphold patents covering its seizure medication Nayzilam, a major win given that generic-drug maker Cipla Ltd. already admitted to infringement.
See more Life Sciences news